Collectively, these findings highlight the novelty of the pivotal role of c-Myc and SIRT1 as molecular targets in cancer treatment [7,13], and how they are critically involved in Isoimperatorin-induced apoptosis in HCCs as potent molecular targets in liver cancer therapy. This evidence concerns the gene MYC and cancer.